PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2012

Authors

  • Fábio F. O. Rodrigues Instituto do Câncer Doutor Arnaldo Vieira de Carvalho
  • Etiénne A. Bastos Instituto do Câncer Doutor Arnaldo Vieira de Carvalho
  • Laís A. Inaba Instituto do Câncer Doutor Arnaldo Vieira de Carvalho
  • Eveline A. Silva Instituto do Câncer Doutor Arnaldo Vieira de Carvalho
  • Rodrigo M. Silva Instituto do Câncer Doutor Arnaldo Vieira de Carvalho
  • Carlos E. Fristachi Instituto do Câncer Doutor Arnaldo Vieira de Carvalho

Downloads

Download data is not yet available.

Downloads

Published

2018-06-07

How to Cite

Rodrigues, F. F. O., Bastos, E. A., Inaba, L. A., Silva, E. A., Silva, R. M., & Fristachi, C. E. (2018). PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2012. Mastology, 28, 51. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/663

Issue

Vol. 28 (2018): Supplement 1

Section

E-poster

License

Copyright (c) 2018 Fábio F. O. Rodrigues, Etiénne A. Bastos, Laís A. Inaba, Eveline A. Silva, Rodrigo M. Silva, Carlos E. Fristachi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.